PNRI researchers identified a severe outbreak of a rare contagious cancer in Puget Sound clams and traced its likely origins to Atlantic Coast populations.
Despite a challenging year for research funding, PNRI scientists moved discovery forward with 21 studies in the past year, shedding light on genetic disorders, cancer biology, and hidden patterns in the human genome – breakthroughs that demonstrate the impact of continued investment in biomedical research.
From cancer in clams to rare disease genomics, PNRI’s 2025 SURI interns spent the summer tackling big questions through hands-on research.
PNRI’s FY24 Annual Report is here! See how we’re advancing genetic research, expanding programs, and shaping the future of human health.
Federal funding cuts disrupt research critical to medical advancements, impacting those needing diagnoses, treatments, and cures. Read PNRI’s op-ed in The Seattle Times to learn more.
Federal funding disruptions have stalled research, delaying critical discoveries. PNRI’s leaders share why stable support matters and how we can protect scientific progress. Read our special message.
From uncovering genetic mysteries to inspiring the next generation, PNRI’s 2024 was a year of breakthroughs, collaboration, and discovery. Read the highlights!
PNRI’s Dr. Michael Metzger kicks off Tech Alliance’s 2024-25 Discovery Series on Friday, September 13th at Slalom Hawk Tower. Join us for this presentation!
Explore Dr. Michael Metzger’s groundbreaking research on contagious cancer in clams, uncovering insights that could revolutionize cancer treatment in humans.
The Summer Undergraduate Research Internship (SURI) is integral in PNRI, where scientists value mentoring the next generation. This summer we proudly hosted ten exceptional interns with diverse interests and career goals as they got hands-on training in our laboratories.